輸入代號或公司名稱後按 Enter
4120

友華

+1.10 (+2.39%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
47.102成交張數本益比0.78股價淨值比8.49%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度資產總額(億)母公司權益(億)負債比率流動比率每股淨值ROE(近四季)ROA(近四季)營業現金流(億)自由現金流(億)
2026Q21185246.1%1.1660.28-10.1%-4.8%-3.1-3.4
2026Q11165741.8%1.3865.34-7.8%-3.7%0.2-0.5
2025Q41226339.8%1.4772.48-9.9%-4.8%-1.6-1.8
2025Q31246936.5%1.6579.04-7.7%-3.7%-1.6-1.8
2025Q21226243.7%1.3971.48-5.6%-2.6%0.3-0.6
2025Q11185547.6%1.1163.48-7.5%-3.1%-0.1-0.3
2024Q41165249.7%1.2059.53-6.5%-2.5%1.00.9
2024Q31235252.3%0.9860.194.4%1.6%0.70.4
2024Q21255352.5%1.0061.053.4%1.2%-1.8-1.9
2024Q11093859.8%1.0543.270.8%0.2%-1.1-1.2
2023Q41083561.5%1.1440.514.5%1.4%2.92.9
2023Q31133563.1%1.0940.77-7.6%-2.3%-1.2-1.3
2023Q21103264.9%1.0337.14-12.9%-3.8%-1.3-1.9
2023Q11073165.3%1.1335.33-10.0%-3.0%0.70.6
2022Q41042967.0%1.1033.76-10.6%-3.1%-0.5-1.9
2022Q31002965.8%1.1533.54-3.3%-1.0%0.0-0.1
2022Q2982964.7%1.2033.921.6%0.5%-3.1-3.3
2022Q11003164.3%1.2435.214.4%1.5%1.4-3.1
2021Q4942963.3%1.2133.913.9%1.4%2.0-7.3
2021Q3862861.4%1.2432.00-2.7%-1.0%0.7-1.0
2021Q2833057.7%1.3734.10-1.5%-0.6%0.3-3.3
2021Q1823252.4%1.7136.972.7%1.1%-2.2-2.5
2020Q4823252.1%1.7836.996.2%2.5%1.71.7
2020Q3803349.7%1.9437.988.1%3.4%-0.0-0.1
2020Q2813351.7%1.7738.519.5%4.0%2.42.3
2020Q1803350.9%1.8238.157.0%3.1%2.00.6
2019Q4793251.6%1.7336.837.6%3.3%-0.7-1.0
2019Q3783249.5%1.8337.437.1%3.2%0.70.2
2019Q2763248.3%1.9337.228.9%4.0%2.62.4
2019Q1743442.4%2.5439.597.1%3.4%-0.4-0.4
2018Q4723342.8%2.3137.847.5%3.5%-1.7-2.1
2018Q3693341.5%2.1537.957.3%3.5%0.40.2
2018Q2673240.7%2.2036.9210.0%4.9%0.90.7
2018Q1673437.3%2.5639.0112.7%6.5%2.62.3
2017Q4673338.4%2.0837.6714.3%7.0%-0.8-0.2
2017Q3673337.6%2.3437.8918.6%9.0%0.2-0.3
2017Q2623237.8%2.3936.4516.4%7.8%4.33.6
2017Q1623236.4%2.8236.9814.9%7.7%2.20.6
2016Q4653139.6%2.6436.25-0.4-0.8
2016Q3643040.1%2.7534.74-0.5-1.1